<DOC>
	<DOCNO>NCT01362322</DOCNO>
	<brief_summary>The purpose study compare immunogenicity safety booster dose BoostrixTM administer new syringe presentation BoostrixTM administer previous syringe presentation healthy adolescent age 10-15 year .</brief_summary>
	<brief_title>Immunogenicity Safety BoostrixTM Using New Syringe 10 15-year Old Adolescents</brief_title>
	<detailed_description>The protocol update follow Protocol amendment 1 date 03 August 2011 lead update exclusion criterion allow subject Mexico receive flu vaccine accordance local standard care . The protocol update follow Protocol amendment 2 date 14 December 2011 due recruitment constraint result DT/dTpa vaccination campaign country . The inclusion exclusion criterion amend allow participation already receive 6th dose diphtheria , tetanus and/or pertussis contain vaccine .</detailed_description>
	<mesh_term>Diphtheria</mesh_term>
	<criteria>Subject 's parent ( ) /Legally Acceptable Representative ( ) subject investigator believe willing comply requirement protocol . A male female 10 15 year age time booster vaccination . Prior protocol amendment 2 , subject previously receive 5 dos diphtheriatetanuspertussis vaccine ( whole cell/acellular [ w/a ] ) part primary booster vaccination , line local recommendation . After protocol amendment 2 , subject previously receive 6 dos either DT ( P ) ( w/a ) / dTpa vaccine part primary booster vaccination , line local recommendation . Healthy subject determine investigator base medical history clinical examination enter study . Written inform consent obtain study entry parent ( ) / Legally Acceptable Representative ( ) subject . Written inform assent obtain subject addition inform consent sign parent ( ) / Legally Acceptable Representative ( ) , require local regulation . Female subject nonchildbearing potential may enrol study . Female subject childbearing potential may enrol study , subject : negative pregnancy test day vaccination , sexually active , practiced adequate contraception 30 day prior vaccination , agree continue adequate contraception entire treatment period 2 month booster vaccination . Child care . Use investigational nonregistered product study vaccine within 30 day precede booster dose study vaccine , plan use study period . Chronic administration immunosuppressant immunemodifying drug within six month prior booster dose . Planned administration/administration vaccine foreseen study protocol within 30 day booster dose vaccine exception influenza vaccine allow 7 day study vaccine dose , plan period â‰¥ 7 day study vaccine dose . Concurrently participate another clinical study , time study period , subject expose investigational noninvestigational product . A history previous intercurrent diphtheria , tetanus pertussis disease . A history vaccination diseases since 5th 6th dose DT ( P ) /dT ( pa ) . For subject receive 6th dose diphtheria , tetanus and/or pertussis contain vaccine , interval last DT ( P ) /dT ( pa ) vaccination administration study vaccine least 18 month . Occurrence follow adverse event previous administration Boostrix vaccine : know hypersensitivity component vaccine , show sign hypersensitivity previous administration diphtheria , tetanus pertussis vaccine , encephalopathy unknown aetiology occur within 7 day follow previous vaccination pertussiscontaining vaccine , transient thrombocytopenia neurological complication follow early immunisation diphtheria and/or tetanus . Any confirm suspected immunosuppressive immunodeficient condition , base medical history physical examination . History reaction hypersensitivity likely exacerbate component vaccine . Administration immunoglobulins and/or blood product within 3 month precede first dose study vaccine plan administration study period . Acute disease and/or fever time enrolment . Pregnant lactate female . Female plan become pregnant planning discontinue contraceptive precaution , applicable .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>dTpa</keyword>
	<keyword>Boostrix</keyword>
</DOC>